Read More 2 minute read Health and Medicine FDA approves omalizumab for food allergy reactions based on NIH research Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights… bychemistadminFebruary 17, 2024